I call the meeting back to order.
I'd like to welcome our final panel of witnesses for this evening. Under the programming motion that is guiding us through these proceedings, we are not to sit past 8:30, and I'd like to wrap up a little before 8:30 so that we can pass the budget, just to give you an idea of the timeline.
We extend a big welcome to the witnesses who have joined us here this evening. We have, from the Canadian Pharmacists Association, Joelle Walker, vice-president, public and professional affairs.
We welcome, from the Heart and Stroke Foundation of Canada, Manuel Arango, vice-president, policy and advocacy. From the National Indigenous Diabetes Association Incorporated, we have Céleste Thériault, executive director; and from the Society of Obstetricians and Gynaecologists of Canada, we welcome Dr. Diane Francoeur, chief executive officer.
You're probably aware that opening statements are five minutes in length and are given in the order in which you're listed on the notice of meeting, so we're going to begin with the Canadian Pharmacists Association.
Ms. Walker, welcome to the committee. You have the floor.